Strategy
Biotech
+8%
By Grow
1 Year Historical Return
Biotechnology companies are developing the next generation of therapies across gene editing, immunology, and novel drug platforms. On a set weekly cadence, the portfolio rebalances when any holding drifts more than 5% from its target weight.
Amgen
13%
Regeneron Pharmaceuticals
13%
Moderna
13%
Vertex Pharmaceuticals
13%
Capricor Therapeutics
13%
Enlivex Therapeutics
13%
AbbVie
13%
Pfizer
13%
